Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The three purposes of this study are the following:
- To compare during a 6-month treatment the safety and effectiveness of idrabiotaparinux
(SSR126517) with that of idraparinux (SR34006), taking into account new events of deep
venous thrombosis (DVT) and pulmonary embolism (PE), and bleeding risk;
- To compare the activities of idrabiotaparinux and idraparinux directly in blood during
and after a 6-month treatment;
- To check the ability of avidin (SSR29261) to reverse the blood thinning activity of
idrabiotaparinux at the end of a 6-month treatment period.